Christopher McCann
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments
- Uterine Myomas and Treatments
Papers in
-
- Cell death mechanisms and regulation 4
- Biochemical and Molecular Research 2
- Surgery 5
- Healthcare Technology and Patient Monitoring 2
- Co-authors
- John O. Schorge (5 shared papers)Marcela G. del Carmen (4 shared papers)Whitfield B. Growdon (5 shared papers)David M. Boruta (4 shared papers)Emma Kerr (3 shared papers)Daniel B. Longley (7 shared papers)Nyree Crawford (5 shared papers)Annekathryn Goodman (3 shared papers)
- Journals
- Cell Death and Disease (2 papers)Molecular Cancer Therapeutics (1 paper)FEBS Journal (1 paper)American Journal of Obstetrics and Gynecology (1 paper)Gynecologic Oncology (1 paper)
- Partner nations
- United KingdomUnited StatesIreland
In The Last Decade
Christopher McCann
20 papers receiving 391 citations
Peers
Comparison fields: 5 of 57
- Reproductive Medicine 136
- Obstetrics and Gynecology 80
- Cancer Research 71
- Oncology 117
- Immunology 63
Countries citing papers authored by Christopher McCann
This map shows the geographic impact of Christopher McCann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher McCann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher McCann more than expected).
Fields of papers citing papers by Christopher McCann
This network shows the impact of papers produced by Christopher McCann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher McCann. The network helps show where Christopher McCann may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher McCann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Surgical debulking of ovarian cancer: what difference does it make? | 2010 | 59 |
| 2 | 2011 | 57 | |
| 3 | 2020 | 40 | |
| 4 | 2010 | 32 | |
| 5 | 2016 | 32 | |
| 6 | Laparoscopic surgical staging of early ovarian cancer. | 2011 | 29 |
| 7 | 2011 | 28 | |
| 8 | 2021 | 21 | |
| 9 | 2020 | 19 | |
| 10 | 2021 | 18 | |
| 11 | 2018 | 12 | |
| 12 | 2011 | 9 | |
| 13 | 2019 | 9 | |
| 14 | 2019 | 6 | |
| 15 | 2013 | 6 | |
| 16 | 2022 | 6 | |
| 17 | 2018 | 5 | |
| 18 | 2021 | 4 | |
| 19 | 2021 | 2 | |
| 20 | 2021 | 1 |
About Christopher McCann
Christopher McCann is a scholar working on Molecular Biology, Surgery, Reproductive Medicine, Epidemiology and Oncology, having authored 20 papers that have together received 395 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (5 papers), Cell death mechanisms and regulation (4 papers), Endometrial and Cervical Cancer Treatments (3 papers), Endometriosis Research and Treatment (3 papers), Phagocytosis and Immune Regulation (2 papers), Healthcare Technology and Patient Monitoring (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Biochemical and Molecular Research (2 papers). The work is most often cited by research in Reproductive Medicine (136 citations), Obstetrics and Gynecology (80 citations), Cancer Research (71 citations), Oncology (117 citations) and Immunology (63 citations). Christopher McCann has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include John O. Schorge, Marcela G. del Carmen, Whitfield B. Growdon, David M. Boruta, Emma Kerr, Daniel B. Longley, Nyree Crawford, Annekathryn Goodman, Tamas Sessler and Simon S. McDade. Their work appears in journals such as Cell Death and Disease, Molecular Cancer Therapeutics, FEBS Journal, American Journal of Obstetrics and Gynecology and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.